Contribution of platelet glycoprotein VI to the thrombogenic effect of collagens in fibrous atherosclerotic lesions

被引:73
作者
Cosemans, JMEM
Kuijpers, MJE
Lecut, C
Loubele, STBG
Heeneman, S
Jandrot-Perrus, M
Heemskerk, JWM
机构
[1] Univ Maastricht, CARIM, Dept Human Biol, NL-6200 MD Maastricht, Netherlands
[2] Univ Maastricht, Dept Biochem, CARIM, NL-6200 MD Maastricht, Netherlands
[3] Univ Paris 07, INSERM, Fac Xavier Bichat, E348, Paris, France
[4] Univ Maastricht, CARIM, Dept Pathol, NL-6200 MD Maastricht, Netherlands
关键词
collagen; plaque; platelets; thrombin; thrombus;
D O I
10.1016/j.atherosclerosis.2004.12.037
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Collagens (types I and III) are among the strongest thrombus-forming components of the vascular subendothelium. We compared the thrombogenic effects of four collagen-containing advanced atherosclerotic lesions with those of purified types I and III collagen fibers. Cellfree homogenates from the human plaques effectively promoted platelet adhesion and aggregate formation under high-shear flow conditions, as well as exposure of procoagulant phosphatidylserine (PS) on platelets. With all plaques, blocking of the glycoprotein VI (GPVI) receptor for collagen abolished aggregation and PS exposure. Blocking of platelet ADP receptors resulted in similar, but less complete inhibitory effects. Type I collagen was more potent than type III collagen in inducing aggregation and PS exposure under flow, via stimulation of GPVI and ADP receptors. Type I collagen also more strongly enhanced thrombin generation with platelets and tissue factor, again via GPVI activation and PS exposure. The plaque material enhanced thrombin generation, partly due to the presence of tissue factor and partly via GPVI and ADP receptors. Together, these results indicate that in advanced plaques collagen type I is a major trigger of thrombus formation and PS exposure, acting via GPVI and ADP release, while tissue factor directly enhances coagulation. (D 2005 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:19 / 27
页数:9
相关论文
共 30 条
[1]   Local inhibition of tissue factor reduces the thrombogenicity of disrupted human atherosclerotic plaques - Effects of tissue factor pathway inhibitor on plaque thrombogenicity under flow conditions [J].
Badimon, JJ ;
Lettino, M ;
Toschi, V ;
Fuster, V ;
Berrozpe, M ;
Chesebro, JH ;
Badimon, L .
CIRCULATION, 1999, 99 (14) :1780-1787
[2]  
Badimon L, 2001, THROMB HAEMOSTASIS, V86, P356
[3]   Collagens and atherosclerosis [J].
Barnes, MJ ;
Farndale, RW .
EXPERIMENTAL GERONTOLOGY, 1999, 34 (04) :513-525
[4]   CHARACTERIZATION OF THE RELATIVE THROMBOGENICITY OF ATHEROSCLEROTIC PLAQUE COMPONENTS - IMPLICATIONS FOR CONSEQUENCES OF PLAQUE RUPTURE [J].
FERNANDEZORTIZ, A ;
BADIMON, JJ ;
FALK, E ;
FUSTER, V ;
MEYER, B ;
MAILHAC, A ;
WENG, D ;
SHAH, PK ;
BADIMON, L .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1994, 23 (07) :1562-1569
[5]  
Heemskerk JWM, 1999, THROMB HAEMOSTASIS, V81, P782
[6]  
Hemker HC, 2000, THROMB HAEMOSTASIS, V83, P589
[7]   Calibrated automated thrombin generation measurement in clotting plasma [J].
Hemker, HC ;
Giesen, P ;
Al Dieri, R ;
Regnault, V ;
de Smedt, E ;
Wagenvoord, R ;
Lecompte, T ;
Béguin, S .
PATHOPHYSIOLOGY OF HAEMOSTASIS AND THROMBOSIS, 2003, 33 (01) :4-15
[8]  
JEYNES BJ, 1981, ARCH PATHOL LAB MED, V105, P353
[9]   Complementary roles of platelet glycoprotein VI and integrin α2β1 in collagen-induced thrombus formation in flowing whole blood ex vivo [J].
Kuijpers, MJE ;
Schulte, V ;
Bergmeier, W ;
Lindhout, T ;
Brakebusch, C ;
Offermanns, S ;
Fässler, R ;
Heemskerk, JWM ;
Nieswandt, B .
FASEB JOURNAL, 2003, 17 (02) :685-+
[10]   Platelet purinergic receptors [J].
Kunapuli, SP ;
Dorsam, RT ;
Kim, S ;
Quinton, TM .
CURRENT OPINION IN PHARMACOLOGY, 2003, 3 (02) :175-180